Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
5.19
+0.59 (12.83%)
At close: Nov 26, 2025, 4:00 PM EST
5.12
-0.07 (-1.35%)
After-hours: Nov 26, 2025, 7:59 PM EST

Capricor Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
237627151957170
Upgrade
Market Cap Growth
-62.98%316.72%57.92%34.76%0.89%1046.92%
Upgrade
Enterprise Value
153544124493035
Upgrade
Last Close Price
5.1913.804.893.862.933.43
Upgrade
PS Ratio
21.1728.185.9837.37288.92226.06
Upgrade
PB Ratio
2.834.316.668.092.262.49
Upgrade
P/TBV Ratio
2.834.316.668.092.262.49
Upgrade
P/FCF Ratio
---61.25--
Upgrade
P/OCF Ratio
---19.39--
Upgrade
EV/Sales Ratio
13.7724.434.9419.10122.30113.31
Upgrade
EV/FCF Ratio
---31.31--
Upgrade
Debt / Equity Ratio
0.170.010.100.220.090.01
Upgrade
Debt / FCF Ratio
---1.64--
Upgrade
Asset Turnover
0.100.190.460.060.010.01
Upgrade
Quick Ratio
3.507.701.591.788.5411.01
Upgrade
Current Ratio
3.597.771.631.828.8211.33
Upgrade
Return on Equity (ROE)
-107.79%-48.16%-129.63%-134.49%-67.23%-77.95%
Upgrade
Return on Assets (ROA)
-49.39%-23.21%-27.66%-40.60%-34.46%-37.42%
Upgrade
Return on Capital (ROIC)
-64.37%-30.98%-76.81%-76.41%-41.71%-48.40%
Upgrade
Return on Capital Employed (ROCE)
-88.20%-28.50%-87.70%-112.00%-56.30%-43.30%
Upgrade
Earnings Yield
-34.55%-6.45%-14.80%-30.43%-28.30%-19.47%
Upgrade
FCF Yield
-28.82%-6.62%-18.36%1.63%-25.45%-15.12%
Upgrade
Buyback Yield / Dilution
-43.02%-31.52%-9.06%-6.34%-48.28%-319.55%
Upgrade
Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q